T. N. Athmaram

Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine Candidate

Shweta Saraswat, T. N. Athmaram, Manmohan Parida et al. · PLoS neglected tropical diseases · 2016 · 72 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: Presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection

Meredith Stewart, Chrysostomos Ι. Dovas, E. Chatzinasiou et al. · Vaccine · 2012 · 54 citations

Veterinary Medicine, Infectious Diseases, Veterinary Microbiology +14

Characterization of Protection Afforded by a Bivalent Virus-Like Particle Vaccine against Bluetongue Virus Serotypes 1 and 4 in Sheep

Ana Cristina Pérez de Diego, T. N. Athmaram, Meredith Stewart et al. · PLoS ONE · 2011 · 49 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus

Yuta Kanai, Piet A. van Rijn, Mieke A. Maris-Veldhuis et al. · Vaccine · 2014 · 35 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Influence of copy number on the expression levels of pandemic influenza hemagglutinin recombinant protein in methylotrophic yeast Pichia pastoris

T. N. Athmaram, Shweta Saraswat, M. Kameswara Rao et al. · Virus Genes · 2012 · 28 citations · Full text

Life Sciences, Microbiology, Molecular Biology +15